Inventor
NANNAPANENI VENKAIAH CHOWDARY
IN27 patents
⚠️ This page may combine multiple inventors who share the name “NANNAPANENI VENKAIAH CHOWDARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NATCO PHARMA LTD
20 patentsUS9440959B2Sep 13, 2016
Process for the preparation of nilotinib
NATCO PHARMA LTD6 citations79
US10040778B2Aug 7, 2018
Anhydrous lenalidomide form-I
NATCO PHARMA LTD1 citations58
US9108945B2Aug 18, 2015
Anhydrous lenalidomide form-I
NATCO PHARMA LTD2 citations58
US12522611B2Jan 13, 2026
Process for the preparation of high pure Eribulin and its Mesylate salt
NATCO PHARMA LTD0 citations56
US11111228B2Sep 7, 2021
Process for the preparation of pomalidomide and its purification
NATCO PHARMA LTD0 citations55
US11008296B2May 18, 2021
Intermediates for the preparation of eribulin thereof
NATCO PHARMA LTD0 citations51
US10966971B2Apr 6, 2021
Pharmaceutical compositions of pomalidomide
NATCO PHARMA LTD0 citations47
US10047088B2Aug 14, 2018
1H-1,8-naphthyridin-2-ones as anti proliferative compounds
NATCO PHARMA LTD0 citations45
US9765072B2Sep 19, 2017
1H-1,8-naphthyridin-2ones as anti proliferative compounds
NATCO PHARMA LTD1 citations45
US11465988B2Oct 11, 2022
Process for the preparation of Tipiracil hydrochloride and intermediates thereof
NATCO PHARMA LTD0 citations43
US11091470B2Aug 17, 2021
Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride
NATCO PHARMA LTD0 citations42
US10383872B2Aug 20, 2019
Pharmaceutical compositions comprising phenylaminopyrimidine derivative
NATCO PHARMA LTD0 citations42
US10800771B2Oct 13, 2020
Process for the preparation of dasatinib polymorph
NATCO PHARMA LTD0 citations41
US12534467B2Jan 27, 2026
Process for the preparation of Acalabrutinib
NATCO PHARMA LTD0 citations40
US10626117B2Apr 21, 2020
Process for the preparation of Ibrutinib
NATCO PHARMA LTD0 citations40
US11414421B2Aug 16, 2022
Process for the preparation of ribociclib succinate and its novel crystalline forms thereof
NATCO PHARMA LTD0 citations36
US10870650B2Dec 22, 2020
Process for the preparation of amorphous idelalisib
NATCO PHARMA LTD0 citations36
US9227948B2Jan 5, 2016
Process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[D][1,3]dioxol-4-yl)acetic acid derivatives
NATCO PHARMA LTD0 citations33
US10106554B2Oct 23, 2018
7-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugs
NATCO PHARMA LTD0 citations32
US10604505B2Mar 31, 2020
Modified process for the preparation of Ceritinib and amorphous form of Ceritinib
NATCO PHARMA LTD0 citations30